A study to compare Kashmaryadi medicated ghee taken by mouth and Uttar Basti therapy for treating female infertility, especially in women who are not releasing eggs properly or whose fallopian tubes are blocked.

A Clinical comparative Evaluation of the Efficacy of Kashmaryadi Ghritapaan and Uttarbasti in the Managment of Stree Bandhyattava With Special Reference to Anovulation and Tubal Blockage.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/02/104094

Enrollment

Registered

2026-02-17

Start date

Unknown

Completion date

Unknown

Last updated

2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O268- Other specified pregnancy relatedconditions

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Married women with Age between 23 to 40 years. 2.Diagnosed or Undiagnosed Patient of primary and secondary infertility. 3.Patients having Hormonal imbalance related of Ovulatory Dysfunction (Anovulation). 4.Patients of partial, unilateral or bilateral tubal blockage.

Exclusion criteria

Exclusion criteria: 1.Age below 23 and above 40 years. 2.Patients having any systemic disorders like Hypertension, Diabetes etc. 3.Patient with congenital and structural uterine abnormalities like fibroid polyps, endometriosis, adenomyosis etc. 4.Patients taking oral contraceptive pills. 5.Patients coming with delayed menstrual cycle of more than three months.

Design outcomes

Primary

Measure	Time frame
1.To compare the efficacy of Kashmaryadi Ghritapaan and Kashmaryadi Ghrita Uttarbasti in management of Stree Bandhyattava with special reference to Anovulation and Tubal Blockage. 2.To study etiopathogenesis of Stree Bandhyattava especially on anovulation and Tubal Blockage.Timepoint: 3 Follow up with trial drug and 1 Follow up without trial drug. 1) 1st Follow up- After completion of 1st menstrual cycle 2) 2nd Follow up-After completion of 2nd menstrual cycle 3) 3rd Follow up-After completion of 3rd menstrual cycle 4) 4th Follow up-After completion of 4th menstrual cycle	—

Measure

Time frame

1.To compare the efficacy of Kashmaryadi Ghritapaan and Kashmaryadi Ghrita Uttarbasti in management of Stree Bandhyattava with special reference to Anovulation and Tubal Blockage. 2.To study etiopathogenesis of Stree Bandhyattava especially on anovulation and Tubal Blockage.Timepoint: 3 Follow up with trial drug and 1 Follow up without trial drug. 1) 1st Follow up- After completion of 1st menstrual cycle 2) 2nd Follow up-After completion of 2nd menstrual cycle 3) 3rd Follow up-After completion of 3rd menstrual cycle 4) 4th Follow up-After completion of 4th menstrual cycle

—

Secondary

Measure	Time frame
1.To provide cost effective, easily available comparatively safe and effective treatment for infertile female patient. 2.To study the complications of trial drug if any during and after the clinical trial.Timepoint: 3 Follow up with trial drug and 1 Follow up without trial drug. 1) 1st Follow up- After completion of 1st menstrual cycle 2) 2nd Follow up-After completion of 2nd menstrual cycle 3) 3rd Follow up-After completion of 3rd menstrual cycle 4) 4th Follow up-After completion of 4th menstrual cycle	—

Measure

Time frame

1.To provide cost effective, easily available comparatively safe and effective treatment for infertile female patient. 2.To study the complications of trial drug if any during and after the clinical trial.Timepoint: 3 Follow up with trial drug and 1 Follow up without trial drug. 1) 1st Follow up- After completion of 1st menstrual cycle 2) 2nd Follow up-After completion of 2nd menstrual cycle 3) 3rd Follow up-After completion of 3rd menstrual cycle 4) 4th Follow up-After completion of 4th menstrual cycle

—

Countries

India

Contacts

Public ContactProfShashi Sharma

State Ayurvedic College and Hospital Tulsidas Marg Old Haider Ganj Turiyaganj,Lucknow

shashi.chd98@gmail.com8795545443

Outcome results